Studies suggested that GBS follows a simplified model in which inflammatory cytokines (IFNγ, TNFα, IL6, and IL1) are disease promoting, while anti-inflammatory cytokines serve as a countermeasure to limit and modulate the inflammatory response; however, the exact mechanism remains elusive. The gene discussed is IL6; the disease is Guillain-Barre syndrome.